Synergistic effect of compounds directed to triosephosphate isomerase, a combination to develop drug against trichomoniasis

The development of new drugs is continuous in the world; currently, saving resources (both economic ones and time) and preventing secondary effects have become a necessity for drug developers. Trichomoniasis is the most common nonviral sexually transmitted infection affecting more than 270 million p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Archiv der Pharmazie (Weinheim) 2022-06, Vol.355 (6), p.e2200046-n/a
Hauptverfasser:	Benítez‐Cardoza, Claudia G., Brieba, Luis G., Arroyo, Rossana, Rojo‐Domínguez, Arturo, Vique‐Sánchez, José L.
Format:	Artikel
Sprache:	eng
Schlagworte:	docking Parasitic diseases Sexually transmitted diseases STD synergistic effect Trichomonas vaginalis triosephosphate isomerase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!